drugset / Trial / NCT05099757

The Immunogenicity and Persistence of Booster Dose With Hepatitis B Vaccine in College Students

NCT05099757

Phase 4 Unknown 150 enrolled Shanxi Medical University
NaSingle-groupOpen-labelPrevention

Summary

The anti-HBs produced after hepatitis B vaccination will decrease over time. College students are vaccinated with hepatitis B vaccine at birth, and their antibodies may have decreased significantly. In addition, college students are sexually active population, which has a high risk of HBV infection. It is necessary to study the anti-HBs level of college students, and analyze the strengthening immunization for this special group. This study will analyze the immunogenicity, immune persistence, and safety of booster dose of intramuscular 20 µg recombinant hepatitis B vaccines. Different booster vaccination including one-dose (0 month), two-dose (0, 1 months), or three-dose (0, 1, and 6 months) was given according to the antibody production level after booster vaccination among college students.

Timeline

Start
2022-02-20
Primary completion
2022-11-25
Completion
2023-12-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Hepatitis B vaccine Vaccine 20 ug Intramuscular